Production of stem-cell transplants according to good manufacturing practice

Annals of Hematology

Volumn 79, Issue 9, 2000, Pages 469-476

  Bosse, R ^a   Kulmburg, P ^a   von Kalle, C ^b   Engelhardt, M ^b   Dwenger, A ^b   Rosenthal, F ^a   Schulz, G ^a  

^a Cellgenix GmbH   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Good manufacturing practice; Stem cell transplants

Indexed keywords

CRYOPRESERVATION; FOOD AND DRUG ADMINISTRATION; GENE TRANSFER; GOOD MANUFACTURING PRACTICE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEGAL ASPECT; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RETROVIRUS; REVIEW;

GERMANY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LABORATORY TECHNIQUES AND PROCEDURES; LEGISLATION, MEDICAL; QUALITY CONTROL; UNITED STATES;

EID: 0033801775     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770000176     Document Type: Review

References (34)

1. Blood and marrow transplantation activity in Europe 1997
2. Proposed approach to regulation of cellular and tissue-based products
3. Guidance for industry: For the submission of chemistry, manufacturing and controls and establishment description information for human blood and blood components intended for transfusion or for further manufacture and for the completion of form FDA 356h 'Application to market a new drug, biologic or an antibiotic drug for human use'
4. Richtlinien zur transplantation von stammzellen aus nabelschnurblut
5. Manufacture of investigational medicinal products. Revision of annex to the EU guide to good manufacturing practice
6. Richtlinien zur transplantation peripherer blutstammzellen
7. Good manufacturing practice production of human stem cells for somatic cell and gene therapy
8. Manufacture of sterile medicinal product. Revision of Annex I to the EU Guide to good manufacturing practice
9. Guideline on the excipients in the label and package leaflet of medicinal products for human use
10. Guidance for industry: Revised precautionary measures to reduce the possible risk of transmission of Creutzfeldt-Jakob Disease (CJD) and new variant Creutzfeldt-Jakob Disease (nvCJD) by blood and blood products
11. Revisions to the requirements applicable to blood, blood components, and source plasma
12. Requirements for human blood donors for evidence of infection due to communicable disease agents and requirements for blood components, and blood derivatives
13. Test for sterility according to the regulations of the European Pharmacopoeia Supplement
14. + cells using immunoaffinity (CellPro) and immunomagnetic (Clinimacs) selection devices for autologous and allogeneic transplantation
15. + selected peripheral blood stem cells (PBSC) in auto-logous and allogeneic transplantation
16. Outcomes among 562 recipients of placental-blood transplants from unrelated donors
17. Placental and/or umbilical cord blood: An alternative source of hematopoietic stem cells for transplantation
18. The Milan Cord Blood Bank and the Italian Cord Blood Network
19. Effect of temperature variation and duration from collection to processing of umbilical cord blood units on cell number viability and clonogenic potential
20. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution
21. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group
22. Cord blood transplantation study (COBLT): Cord blood bank standard operating procedures
23. Implementation of a quality system (ISO 9000 series) for placental blood banking
24. Gene transfer into marrow repopulating cells - Comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons
25. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability
26. Efficient serum-free retroviral gene transfer into primitive human hematopoietic progenitor cells by a defined, high-titer, nonconcentrated vector-containing medium
27. Lentiviruses as gene transfer agents for delivery to non-dividing cells
28. Transduction of hematopoietic stem cells in humans and in nonhuman primates